Zacks5d agobearish
IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent shares down 13% despite revenue growth.
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
310last 24h
1814last 7d
322🟢 bullish (7d)
187🔴 bearish (7d)
129publishers
Zacks7d agobearish
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue EstimatesUltragenyx (RARE) delivered earnings and revenue surprises of -18.96% and -15.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
